Laboratory Corp of America Holdings (LabCorp) is a provider of clinical laboratory services and end-to-end drug development support. It focuses on the development and commercialization of a range of diagnostic technologies and testing services. The company offers clinical diagnostics laboratory services such as core testing, genomic and esoteric testing. Its services include general and specialty laboratory testing, bone marrow and human leukocyte antigen (HLA) testing, clinical trials services, drug testing services, deoxyribonucleic acid (DNA) identification services, forensic identity services, insurance health plan services, paternity testing services, patient services, personalized medicine, and hospital services. It also offers drug development services through Covance. It offers services to managed care organizations, physicians, hospitals, government agencies, and biotechnology and pharmaceutical companies through a network of primary laboratories and patient service centers. The company has operations across the US, Belgium, China, Singapore, the UK, and other countries. LabCorp is headquartered in Burlington, North Carolina, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
The report analyzes all pipeline products in development for the company Laboratory Corp of America Holdings
The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
The report provides detailed description of products in development, technical specification and functions
The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
To formulate effective Research & Development strategies
Develop market-entry and market expansion strategies
Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note:Some sections may be missing if data is unavailable for the company
Laboratory Corp of America Holdings Company Overview
Laboratory Corp of America Holdings Company Snapshot
Laboratory Corp of America Holdings Pipeline Products and Ongoing Clinical Trials Overview
Laboratory Corp of America Holdings – Pipeline Analysis Overview
Business Description
Laboratory Corp of America Holdings - Key Facts
Laboratory Corp of America Holdings - Major Products and Services
Laboratory Corp of America Holdings Pipeline Products by Development Stage
Laboratory Corp of America Holdings Ongoing Clinical Trials by Trial Status
Laboratory Corp of America Holdings Pipeline Products Overview
ctDNA Based Laboratory Developed Test - Product Status
ctDNA Based Laboratory Developed Test - Product Description
Diagnostic Test - Alzheimer's Disease - Product Status
Diagnostic Test - Alzheimer's Disease - Product Description
Diagnostic Test Kit - Bird Flu - Product Status
Diagnostic Test Kit - Bird Flu - Product Description
Diagnostic Test Kit - Ebola - Product Status
Diagnostic Test Kit - Ebola - Product Description
Diagnostic Test Kit - Polio - Product Status
Diagnostic Test Kit - Polio - Product Description
Diagnostic Test Kit - SARS - Product Status
Diagnostic Test Kit - SARS - Product Description
Discretion Companion - Product Status
Discretion Companion - Product Description
Epilepsy Gene Panel Test - Product Status
Epilepsy Gene Panel Test - Product Description
Flavivirus assay - Product Status
Flavivirus assay - Product Description
Gencaro Companion Diagnostic Test - Product Status
Gencaro Companion Diagnostic Test - Product Description
GenPrecis Precision Monitoring System - Product Status
GenPrecis Precision Monitoring System - Product Description
GenSure Test Strip - Product Status
GenSure Test Strip - Product Description
GenUltimate TBG - Version 2 - Product Status
GenUltimate TBG - Version 2 - Product Description
GenUltimate! TBG - Product Status
GenUltimate! TBG - Product Description
GenUltimate! TBG - 100ct Test Strips - Product Status
GenUltimate! TBG - 100ct Test Strips - Product Description
GenUltimate! TBG - 50ct Test Strips - Product Status
GenUltimate! TBG - 50ct Test Strips - Product Description
Genviro Confirmatory Test - COVID-19 - Product Status
Genviro Confirmatory Test - COVID-19 - Product Description
GenViro Saliva COVID-19 Swift Kit - Home Use - Product Status
GenViro Saliva COVID-19 Swift Kit - Home Use - Product Description
GenViro Saliva COVID-19 Swift Kit - Home Use - Evaluate the GenViro Saliva Swift:10 Test Kit in Patient Walk-in Donor Study
GenViro Saliva COVID-19 Swift Kit - Professional Use - Product Status
GenViro Saliva COVID-19 Swift Kit - Professional Use - Product Description
GenViro Screening COVID-19 Swift Kit - Product Status
GenViro Screening COVID-19 Swift Kit - Product Description
Genviro Screening COVID-19 Swift Kit - Home Use - Product Status
Genviro Screening COVID-19 Swift Kit - Home Use - Product Description
Hepatitis B Virus Resistance Test - Product Status
Hepatitis B Virus Resistance Test - Product Description
Human Papilloma Virus Assay - Product Status
Human Papilloma Virus Assay - Product Description
IntelliGEN Myeloid Test - Product Status
IntelliGEN Myeloid Test - Product Description
MutatorDETECT Assay - Product Status
MutatorDETECT Assay - Product Description
NASH FibroSure Plus - Product Status
NASH FibroSure Plus - Product Description
Next Generation Noninvasive Prenatal Test (NIPT) - Product Status
Next Generation Noninvasive Prenatal Test (NIPT) - Product Description
NGS-Based Human Leukocyte Antigen (HLA) Test - Product Status
NGS-Based Human Leukocyte Antigen (HLA) Test - Product Description
Pan-Cancer Plasma Assay - Product Status
Pan-Cancer Plasma Assay - Product Description
Pan-Cancer Plasma Assay - A Phase II Open Label, Randomized Non-comparative Trial of Nivolumab Alone or in Combination with Ipilimumab for the Treatment of Patients with Advanced Hypermutated Solid Tumors Detected by a Blood Based Assay
PGDx elio Plasma Resolve - Product Status
PGDx elio Plasma Resolve - Product Description
PlasmaSelect-R Liquid Biopsy Test - CLIA - Product Status
PlasmaSelect-R Liquid Biopsy Test - CLIA - Product Description
Precision Diagnostics Tool - Product Status
Precision Diagnostics Tool - Product Description
Respiratory Syncytial Virus Fusion And Neutralizing Antibodies Assay - Product Status